IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Fredi, Micaela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.249
EU - Europa 1.697
AS - Asia 1.175
OC - Oceania 9
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 2
Totale 7.142
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.236
CN - Cina 406
UA - Ucraina 360
SG - Singapore 320
DE - Germania 310
IT - Italia 301
HK - Hong Kong 291
FI - Finlandia 161
RU - Federazione Russa 131
GB - Regno Unito 122
IE - Irlanda 104
TR - Turchia 103
PL - Polonia 63
FR - Francia 58
SE - Svezia 32
IN - India 18
BE - Belgio 14
CA - Canada 13
VN - Vietnam 12
AU - Australia 8
MK - Macedonia 7
ID - Indonesia 6
NL - Olanda 6
BR - Brasile 5
CZ - Repubblica Ceca 5
GR - Grecia 5
ES - Italia 4
SA - Arabia Saudita 4
EU - Europa 3
IL - Israele 3
PH - Filippine 3
PK - Pakistan 3
RS - Serbia 3
CH - Svizzera 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CO - Colombia 1
DK - Danimarca 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
HU - Ungheria 1
IQ - Iraq 1
KR - Corea 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
MU - Mauritius 1
MY - Malesia 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
Totale 7.142
Salva come PNG Salva come JPEG
Città #
Fairfield 717
Woodbridge 481
Ashburn 355
Houston 295
Hong Kong 291
Jacksonville 286
Cambridge 266
Singapore 266
Seattle 234
Chandler 219
Wilmington 217
Ann Arbor 213
Princeton 173
Helsinki 137
New York 106
Dublin 104
Istanbul 97
Beijing 75
Nanjing 69
Warsaw 63
Brescia 57
Moscow 48
Shanghai 43
San Diego 33
Nanchang 31
Des Moines 27
London 25
Shenyang 24
Hebei 22
Changsha 20
Munich 19
San Francisco 19
Romola 18
Los Angeles 17
Jiaxing 16
Milan 15
Brussels 14
Tianjin 14
Cagliari 12
Dong Ket 12
Jinan 11
Dearborn 10
Nürnberg 10
Rozzano 10
Falkenstein 9
Hangzhou 9
Lancaster 9
Ningbo 9
Verona 9
Bergamo 8
Ottawa 8
Pune 8
Washington 8
Kilburn 7
Rome 7
Ferrara 6
Jakarta 6
Kunming 6
Lappeenranta 6
Orange 6
Pordenone 6
Zhengzhou 6
Genoa 5
Lanzhou 5
Norwalk 5
Prescot 5
Bosio 4
Melbourne 4
Paris 4
Strasbourg 4
Turin 4
Boardman 3
Brno 3
Duncan 3
Fuzhou 3
Guangzhou 3
Indiana 3
New Bedfont 3
Novi Sad 3
Redwood City 3
Rho 3
Riyadh 3
Skopje 3
São Paulo 3
Toronto 3
Acton 2
Amsterdam 2
Athens 2
Atlanta 2
Augusta 2
Bagheria 2
Changchun 2
Chiswick 2
Clearwater 2
Cosenza 2
Crotone 2
Dallas 2
Frankfurt am Main 2
Haikou 2
Kocaeli 2
Totale 5.436
Salva come PNG Salva come JPEG
Nome #
Aicardi-Goutieres syndrome, a rare neurological disease in children: a new autoimmune disorder? 171
Sine causa tetraparesis: A pilot study on its possible relationship with interferon signature analysis and Aicardi Goutières syndrome related genes analysis 162
Prevalence and disease-specific risk factors for Lower Urinary Tract symptoms in Systemic Sclerosis: an international multi-centric study 139
A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus 133
Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study 133
Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome 132
Antiphospholipid antibodies mediate autoimmunity against dying cells. 129
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 128
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 126
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 125
Macrophage activation syndrome in adult systemic lupus erythematosus: Report of seven adult cases from a single Italian rheumatology center 123
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 121
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 120
The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study 120
The clinico-serological spectrum of overlap myositis 120
Treatment and functional outcome of patients with cystoid macular edema: a single-center experience 117
Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years 117
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 117
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 116
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 116
Relationship between endothelial dysfunction, videocapillaroscopy and circulating CD3+CD31+CXCR4+ lymphocytes in systemic lupus erythematosus without cardiovascular risk factors 112
Exploring Autoimmunity in a Cohort of Children with Genetically Confirmed Aicardi–Goutières Syndrome 111
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera 110
Systemic vasculitis and pregnancy: a multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 109
Longterm outcome of patients with primary antiphospholipid syndrome: A retrospective multicenter study 109
Risk factors for adverse maternal and fetal outcomes in women with confirmed aPL positivity: Results from a multicenter study of 283 pregnancies 108
Rare autoantibodies to cellular antigens in systemic lupus erythematosus. 107
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 106
The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies. 102
The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases 100
Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study 100
IRF5 is associated with primary antiphospholipid syndrome,but is not a major risk factor 99
Myositis autoantibodies and clinical phenotypes 98
The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus 98
Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis 93
Clinical significance of IgA anti-cardiolipin and IgA anti-β2glycoprotein I antibodies. 92
Anti-topoisomerase-I antibodies in systemic lupus erythematosus and potential association with the presence of anti-dsDNA antibodies 92
Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset 90
Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies. 87
Belimumab decreases flare rate and hinders the expected damage progression in patients with active systemic lupus erythematosus 84
Neutrophil Extracellular Traps (NETs) profiles in patients with incident SLE and lupus nephritis 82
Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis 80
ANTIPHOSPHOLIPID ANTIBODIES AND CEREBROVASCULAR EVENTS. WHICH FACTORS ASSOCIATE WITH ONSET AND RECURRENCE? - POSTER TOURS 78
Letter to editor: New onset/recurrence of inflammatory arthralgia/spondyloarthritis in patients treated with vedolizumab for intestinal bowel disease 78
RELATIONSHIP BETWEEN SLE SUSCEPTIBILITY GENES AND CLINICAL MANIFESTATIONS IN A COHORT OF PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME 78
Should we treat congenital heart block with fluorinated corticosteroids? 73
Semiquantitative analysis of line blot assay for myositis-specific and myositis-associated antibodies: a better performance? 72
A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies. 69
Analysis of C9Orf72 Expansions in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: Preliminary Data 68
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies 67
Systematic Review and Meta-analysis on the Association of Occupational Exposure to Free Crystalline Silica and Rheumatoid Arthritis 65
Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options 64
Inherited thrombophilia in women with poor aPL-related obstetric history: prevalence and outcomes. Survey of 208 cases from the European Registry on Obstetric Antiphospholipid Syndrome cohort 63
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 63
Aseptic meningitis occurring during anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing spondylitis 62
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept 62
Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis 61
A prospective evaluation of endothelial dysfunction in Systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results. 61
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort. 59
Disease course and obstetric outcomes of pregnancies in juvenile idiopathic arthritis: are there any differences among disease subtypes? A single-centre retrospective study of prospectively followed pregnancies in a dedicated pregnancy clinic 59
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry 59
Triple antiphospholipid (aPL) antibodies positivity is associated with pregnancy complications in aPL carriers: A multicenter study on 62 pregnancies 48
Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi2 positive dermatomyositis 45
Use of rituximab in a multicentre cohort of patients with rheumatic diseases during the outbreak of novel SARS-COV-2 infection 45
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus 44
Systematic review and meta-analysis of epidemiological studies on the association of occupational exposure to free crystalline silica and systemic lupus erythematosus 43
Evaluation of a large set of patients with Autoimmune Polyglandular Syndrome from a single reference centre in context of different classifications 42
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 42
Maternal, pregnancy and neonatal outcomes of twin gestations in women with rheumatic diseases: A single-center, case-control study 41
Early echocardiographic alterations in SSc with anti-RNA polymerase III antibodies 39
Autoimmune polyglandular syndrome type 4: experience from a single reference center 38
Reply to: Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis by Castellanos-Moreira et al 37
Managing puerperium in patients with systemic autoimmune diseases: an update 37
Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies. 36
Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis 34
Gender differences in primary antiphospholipid syndrome with vascular manifestations in 433 patients from four European centres 33
Neutrophil Extracellular Traps in the Autoimmunity Context. 32
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis 31
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 31
Association of Natural Killer Cell Ligand Polymorphism, HLAC Asn80Lys, with the Development of Anti-SSA/Ro Associated Congenital Heart Block 30
Topoisomerase I (SCL 70) Autoantibodies 27
Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis 26
Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response 25
Tapering belimumab in patients with systemic lupus erythematosus: a single-centre experience 23
Systemic lupus erythematosus: state of the art on clinical practice guidelines 23
Anti-SSA/Ro positivity and congenital heart block: obstetric and foetal outcome in a cohort of anti-SSA/Ro positive pregnant patients with and without autoimmune diseases 23
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 22
Evaluation of the incidence of melanoma and non-melanoma skin cancer in patients with systemic lupus erythematosus and systemic sclerosis 21
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 20
Obstetric APS 19
Intrauterine fetal deaths related to antiphospholipid syndrome: a descriptive study of 65 women 19
Typing TREX1 gene in patients with systemic lupus erythematosus 19
Systemic Vasculitis and Pregnancy 19
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study 18
Pregnancy in antiphospholipid syndrome: what should a rheumatologist know? 18
Increased COVID-19 mortality in patients with rheumatic diseases: results from the CONTROL-19 study by the Italian Society for Rheumatology 18
Identifying and managing lupus nephritis during pregnancy 18
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence 17
Systemic Lupus Erythematosus: predictive biomarker, detection and role of new autoantibodies and multidisciplinary study of subclinical cardiovascular disorders. 16
Systemic Lupus Erythematosus: predictive biomarker, detection and role of new autoantibodies and multidisciplinary study of subclinical cardiovascular disorders. 16
Totale 7.130
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.809
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.809
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020790 0 0 0 0 0 0 150 170 155 176 54 85
2020/20211.343 27 151 66 138 82 189 52 139 120 185 95 99
2021/2022776 67 83 54 41 12 54 26 60 44 95 71 169
2022/2023752 102 7 9 43 74 208 11 90 126 7 35 40
2023/2024927 55 21 79 114 58 151 37 49 198 26 20 119
2024/2025830 23 38 40 238 195 186 110 0 0 0 0 0
Totale 7.342